Recent Insights into the Role of Gut Microbiota in Diabetic Retinopathy

References

• Zhou H, Peng C, Huang D-S, Liu L, Guan P. microRNA expression profiling based on microarray approach in human diabetic retinopathy: a systematic review and meta-analysis. DNA Cell Biol. 2020;39(3):441–450. doi:10.1089/dna.2019.4942
   PubMed Web of Science ®Google Scholar
• Cecilia O-M, José Alberto C-G, José N-P, et al. Oxidative stress as the main target in diabetic retinopathy pathophysiology. J Diabetes Res. 2019;2019:1–21. doi:10.1155/2019/8562408
   Web of Science ®Google Scholar
• Sharma A. Emerging simplified retinal imaging. Dev Ophthalmol. 2017;60:56–62. doi:10.1159/000459690
   PubMedGoogle Scholar
• Wong TY, Cheung CM, Larsen M, Sharma S, Simó R. Diabetic retinopathy. Nat Rev Dis Primers. 2016;2:16012. doi:10.1038/nrdp.2016.12
   PubMed Web of Science ®Google Scholar
• Gerstein HC, Werstuck GH. Dysglycaemia, vasculopenia, and the chronic consequences of diabetes. Lancet Diabetes Endocrinol. 2013;1(1):71–78. doi:10.1016/s2213-8587(13)70025-1
   PubMed Web of Science ®Google Scholar
• Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366(13):1227–1239. doi:10.1056/NEJMra1005073
   PubMed Web of Science ®Google Scholar
• Maniadakis N, Konstantakopoulou E. Cost effectiveness of treatments for diabetic retinopathy: a systematic literature review. Pharmacoeconomics. 2019;37(8):995–1010. doi:10.1007/s40273-019-00800-w
   PubMed Web of Science ®Google Scholar
• Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–564. doi:10.2337/dc11-1909
   PubMed Web of Science ®Google Scholar
• Zhang G, Chen H, Chen W, Zhang M. Prevalence and risk factors for diabetic retinopathy in China: a multi-hospital-based cross-sectional study. Br J Ophthalmol. 2017;101(12):1591–1595. doi:10.1136/bjophthalmol-2017-310316
   PubMed Web of Science ®Google Scholar
• Scirocco A, Matarrese P, Carabotti M, Ascione B, Malorni W, Severi C. Cellular and molecular mechanisms of phenotypic switch in gastrointestinal smooth muscle. J Cell Physiol. 2016;231(2):295–302. doi:10.1002/jcp.25105
   PubMed Web of Science ®Google Scholar
• Rizk P, Barker N. Gut stem cells in tissue renewal and disease: methods, markers, and myths. Wiley Interdiscip Rev Syst Biol Med. 2012;4(5):475–496. doi:10.1002/wsbm.1176
   PubMed Web of Science ®Google Scholar
• Salarolli RT, Alvarenga L, Cardozo L, et al. Can curcumin supplementation reduce plasma levels of gut-derived uremic toxins in hemodialysis patients? A pilot randomized, double-blind, controlled study. Int Urol Nephrol. 2021;53:1231–1238. doi:10.1007/s11255-020-02760-z
   PubMed Web of Science ®Google Scholar
• Yang CY, Chen TW, Lu WL, et al. Synbiotics alleviate the gut indole load and dysbiosis in chronic kidney disease. Cells. 2021;10(1). doi:10.3390/cells10010114
   Web of Science ®Google Scholar
• Peng J, Lu X, Xie K, et al. Dynamic alterations in the gut microbiota of collagen-induced arthritis rats following the prolonged administration of total glucosides of paeony. Front Cell Infect Microbiol. 2019;9:204. doi:10.3389/fcimb.2019.00204
   PubMed Web of Science ®Google Scholar
• Schoeler M, Caesar R. Dietary lipids, gut microbiota and lipid metabolism. Rev Endocr Metab Disord. 2019;20(4):461–472. doi:10.1007/s11154-019-09512-0
   PubMed Web of Science ®Google Scholar
• Verma A, Xu K, Du T, et al. Expression of human ACE2 in lactobacillus and beneficial effects in diabetic retinopathy in mice. Mol Ther Methods Clin Dev. 2019;14:161–170. doi:10.1016/j.omtm.2019.06.007
   PubMed Web of Science ®Google Scholar
• Nadeem U, Xie B, Movahedan A, et al. High throughput RNA sequencing of mice retina reveals metabolic pathways involved in the gut-retina axis. bioRxiv. 2020. doi:10.1101/2020.10.01.318949
   Google Scholar
• Huang Y, Wang Z, Ma H, et al. Dysbiosis and implication of the gut microbiota in diabetic retinopathy. Front Cell Infect Microbiol. 2021;11:646348. doi:10.3389/fcimb.2021.646348
   PubMed Web of Science ®Google Scholar
• Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet (London, England). 2010;376(9735):124–136. doi:10.1016/s0140-6736(09)62124-3
   PubMed Web of Science ®Google Scholar
• Aiello LP. Diabetic retinopathy and other ocular findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care. 2014;37(1):17–23. doi:10.2337/dc13-2251
   PubMed Web of Science ®Google Scholar
• Hayes AJ, Leal J, Gray AM, Holman RR, Clarke PM. UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82. Diabetologia. 2013;56(9):1925–1933. doi:10.1007/s00125-013-2940-y
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Kowluru A, Veluthakal R, et al. TIAM1-RAC1 signalling axis-mediated activation of NADPH oxidase-2 initiates mitochondrial damage in the development of diabetic retinopathy. Diabetologia. 2014;57(5):1047–1056. doi:10.1007/s00125-014-3194-z
   PubMed Web of Science ®Google Scholar
• Niimi N, Yako H, Takaku S, Chung SK, Sango K. Aldose reductase and the polyol pathway in schwann cells: old and new problems. Int J Mol Sci. 2021;22(3):1031. doi:10.3390/ijms22031031
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Mishra M. Oxidative stress, mitochondrial damage and diabetic retinopathy. Biochim Biophys Acta. 2015;1852(11):2474–2483. doi:10.1016/j.bbadis.2015.08.001
   PubMed Web of Science ®Google Scholar
• Sahajpal N, Kowluru A, Kowluru RA. The regulatory role of Rac1, a small molecular weight GTPase, in the development of diabetic retinopathy. J Clin Med. 2019;8(7):965. doi:10.3390/jcm8070965
   PubMed Web of Science ®Google Scholar
• Mohammad G, Duraisamy AJ, Kowluru A, Kowluru RA. Functional regulation of an oxidative stress mediator, Rac1, in diabetic retinopathy. Mol Neurobiol. 2019;56(12):8643–8655. doi:10.1007/s12035-019-01696-5
   PubMed Web of Science ®Google Scholar
• Luo R, Xiao F, Wang P, Hu YX. lncRNA H19 sponging miR-93 to regulate inflammation in retinal epithelial cells under hyperglycemia via XBP1s. Inflamm Res. 2020;69(3):255–265. doi:10.1007/s00011-019-01312-1
   PubMed Web of Science ®Google Scholar
• Cvitkovic K, Sesar A, Sesar I, et al. Concentrations of selected cytokines and vascular endothelial growth factor in aqueous humor and serum of diabetic patients. Semin Ophthalmol. 2020;35(2):126–133. doi:10.1080/08820538.2020.1755320
   PubMed Web of Science ®Google Scholar
• Spilsbury K, Garrett KL, Shen WY, Constable IJ, Rakoczy PE. Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. Am J Pathol. 2000;157(1):135–144. doi:10.1016/s0002-9440(10)64525-7
   PubMed Web of Science ®Google Scholar
• Hachana S, Fontaine O, Sapieha P, Lesk M, Couture R, Vaucher E. The effects of anti-VEGF and kinin B(1) receptor blockade on retinal inflammation in laser-induced choroidal neovascularization. Br J Pharmacol. 2020;177(9):1949–1966. doi:10.1111/bph.14962
   PubMed Web of Science ®Google Scholar
• Behar-Cohen F, Dernigoghossian M, Andrieu-Soler C, Levy R, Cohen R, Zhao M. Potential antiedematous effects of intravitreous anti-VEGF, unrelated to VEGF neutralization. Drug Discov Today. 2019;24(8):1436–1439. doi:10.1016/j.drudis.2019.05.034
   PubMed Web of Science ®Google Scholar
• Virgili G, Parravano M, Evans JR, Gordon I, Lucenteforte E. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis. Cochrane Database Syst Rev. 2018;10(10):Cd007419. doi:10.1002/14651858.CD007419.pub6
   PubMedGoogle Scholar
• Ouyang H, Mei X, Zhang T, Lu B, Ji L. Ursodeoxycholic acid ameliorates diabetic retinopathy via reducing retinal inflammation and reversing the breakdown of blood-retinal barrier. Eur J Pharmacol. 2018;840:20–27. doi:10.1016/j.ejphar.2018.09.027
   PubMed Web of Science ®Google Scholar
• Gu R, Ding X, Tang W, Lei B, Jiang C, Xu G. A synthesized glucocorticoid- induced leucine zipper peptide inhibits retinal Müller cell gliosis. Front Pharmacol. 2018;9:331. doi:10.3389/fphar.2018.00331
   PubMed Web of Science ®Google Scholar
• Ogura S, Kurata K, Hattori Y, et al. Sustained inflammation after pericyte depletion induces irreversible blood-retina barrier breakdown. JCI Insight. 2017;2(3):e90905. doi:10.1172/jci.insight.90905
   PubMed Web of Science ®Google Scholar
• Mitamura Y, Harada T, Harada C, et al. NF-kappaB in epiretinal membranes after human diabetic retinopathy. Diabetologia. 2003;46(5):699–703. doi:10.1007/s00125-003-1084-x
   PubMed Web of Science ®Google Scholar
• Li J, Zhao F, Wang Y, et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017;5(1):14. doi:10.1186/s40168-016-0222-x
   PubMed Web of Science ®Google Scholar
• Liu R, Hong J, Xu X, et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med. 2017;23(7):859–868. doi:10.1038/nm.4358
   PubMed Web of Science ®Google Scholar
• Yu Y, Mao G, Wang J, et al. Gut dysbiosis is associated with the reduced exercise capacity of elderly patients with hypertension. Hypertens Res. 2018;41(12):1036–1044. doi:10.1038/s41440-018-0110-9
   PubMed Web of Science ®Google Scholar
• Larsen N, Vogensen FK, van den Berg FW, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One. 2010;5(2):e9085. doi:10.1371/journal.pone.0009085
   PubMed Web of Science ®Google Scholar
• de Groot P, Nikolic T, Pellegrini S, et al. Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial. Gut. 2021;70(1):92–105. doi:10.1136/gutjnl-2020-322630
   PubMed Web of Science ®Google Scholar
• Khangwal I, Shukla P. Combinatory biotechnological intervention for gut microbiota. Appl Microbiol Biotechnol. 2019;103(9):3615–3625. doi:10.1007/s00253-019-09727-w
   PubMed Web of Science ®Google Scholar
• Beli E, Yan Y, Moldovan L, et al. Restructuring of the gut microbiome by intermittent fasting prevents retinopathy and prolongs survival in db/db mice. Diabetes. 2018;67(9):1867–1879. doi:10.2337/db18-0158
   PubMed Web of Science ®Google Scholar
• Gronbeck KR, Rodrigues CM, Mahmoudi J, et al. Application of tauroursodeoxycholic acid for treatment of neurological and non-neurological diseases: is there a potential for treating traumatic brain injury? Neurocrit Care. 2016;25(1):153–166. doi:10.1007/s12028-015-0225-7
   PubMed Web of Science ®Google Scholar
• Rizzo G, Passeri D, De Franco F, et al. Functional characterization of the semisynthetic bile acid derivative INT-767, a dual farnesoid X receptor and TGR5 agonist. Mol Pharmacol. 2010;78(4):617–630. doi:10.1124/mol.110.064501
   PubMed Web of Science ®Google Scholar
• Wang XX, Wang D, Luo Y, et al. FXR/TGR5 dual agonist prevents progression of nephropathy in diabetes and obesity. JASN. 2018;29(1):118–137. doi:10.1681/asn.2017020222
   Web of Science ®Google Scholar
• Das T, Jayasudha R, Chakravarthy S, et al. Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy. Sci Rep. 2021;11(1):2738. doi:10.1038/s41598-021-82538-0
   PubMed Web of Science ®Google Scholar
• Zhu L, Sha L, Li K, et al. Dietary flaxseed oil rich in omega-3 suppresses severity of type 2 diabetes mellitus via anti-inflammation and modulating gut microbiota in rats. Lipids Health Dis. 2020;19(1):20. doi:10.1186/s12944-019-1167-4
   PubMed Web of Science ®Google Scholar
• Zaman GS, Zaman F. Relationship between postprandial endotoxemia in nonobese postmenopausal women and diabetic nonobese postmenopausal women. J Nat Sci Biol Med. 2015;6(1):89–93. doi:10.4103/0976-9668.149098
   PubMedGoogle Scholar
• Layoun A, Santos MM. Bacterial cell wall constituents induce hepcidin expression in macrophages through MyD88 signaling. Inflammation. 2012;35(4):1500–1506. doi:10.1007/s10753-012-9463-4
   PubMed Web of Science ®Google Scholar
• Kuwabara WMT, Yokota CNF, Curi R, Alba-Loureiro TC. Obesity and Type 2 Diabetes mellitus induce lipopolysaccharide tolerance in rat neutrophils. Sci Rep. 2018;8(1):17534. doi:10.1038/s41598-018-35809-2
   PubMedGoogle Scholar
• Zhang L, Qin Q, Liu M, Zhang X, He F, Wang G. Akkermansia muciniphila can reduce the damage of gluco/lipotoxicity, oxidative stress and inflammation, and normalize intestine microbiota in streptozotocin-induced diabetic rats. Pathog Dis. 2018;76(4). doi:10.1093/femspd/fty028
   Web of Science ®Google Scholar
• Chelakkot C, Choi Y, Kim DK, et al. Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions. Exp Mol Med. 2018;50(2):e450. doi:10.1038/emm.2017.282
   PubMed Web of Science ®Google Scholar
• Campo GM, Avenoso A, Campo S, D’Ascola A, Nastasi G, Calatroni A. Molecular size hyaluronan differently modulates toll-like receptor-4 in LPS-induced inflammation in mouse chondrocytes. Biochimie. 2010;92(2):204–215. doi:10.1016/j.biochi.2009.10.006
   PubMed Web of Science ®Google Scholar
• Egshatyan L, Kashtanova D, Popenko A, et al. Gut microbiota and diet in patients with different glucose tolerance. Endocr Connect. 2016;5(1):1–9. doi:10.1530/ec-15-0094
   PubMed Web of Science ®Google Scholar
• Sohail MU, Althani A, Anwar H, Rizzi R, Marei HE. Role of the gastrointestinal tract microbiome in the pathophysiology of diabetes mellitus. J Diabetes Res. 2017;2017:9631435. doi:10.1155/2017/9631435
   PubMed Web of Science ®Google Scholar
• Sayed KM, Mahmoud AA. Heat shock protein-70 and hypoxia inducible factor-1α in type 2 diabetes mellitus patients complicated with retinopathy. Acta Ophthalmol. 2016;94(5):e361–366. doi:10.1111/aos.12919
   PubMed Web of Science ®Google Scholar
• Abdulaal M, Haddad NM, Sun JK, Silva PS. The role of plasma kallikrein-kinin pathway in the development of diabetic retinopathy: pathophysiology and therapeutic approaches. Semin Ophthalmol. 2016;31(1–2):19–24. doi:10.3109/08820538.2015.1114829
   PubMed Web of Science ®Google Scholar
• Kim EJ, Lin WV, Rodriguez SM, Chen A, Loya A, Weng CY. Treatment of diabetic macular edema. Curr Diab Rep. 2019;19(9):68. doi:10.1007/s11892-019-1188-4
   PubMed Web of Science ®Google Scholar
• Moubayed NM, Bhat RS, Al Farraj D, Dihani NA, El Ansary A, Fahmy RM. Screening and identification of gut anaerobes (Bacteroidetes) from human diabetic stool samples with and without retinopathy in comparison to control subjects. Microb Pathog. 2019;129:88–92. doi:10.1016/j.micpath.2019.01.025
   PubMed Web of Science ®Google Scholar
• Vagaja NN, Binz N, McLenachan S, Rakoczy EP, McMenamin PG. Influence of endotoxin-mediated retinal inflammation on phenotype of diabetic retinopathy in Ins2 Akita mice. Br J Ophthalmol. 2013;97(10):1343–1350. doi:10.1136/bjophthalmol-2013-303201
   PubMed Web of Science ®Google Scholar
• Singh V, Yeoh BS, Vijay-Kumar M. Gut microbiome as a novel cardiovascular therapeutic target. Curr Opin Pharmacol. 2016;27:8–12. doi:10.1016/j.coph.2016.01.002
   PubMed Web of Science ®Google Scholar
• Karpova T, de Oliveira AA, Naas H, Priviero F, Nunes KP. Blockade of Toll-like receptor 4 (TLR4) reduces oxidative stress and restores phospho-ERK1/2 levels in Leydig cells exposed to high glucose. Life Sci. 2020;245. doi:10.1016/j.lfs.2020.117365
   Web of Science ®Google Scholar
• Rajamani U, Jialal I. Hyperglycemia induces Toll-like receptor-2 and −4 expression and activity in human microvascular retinal endothelial cells: implications for diabetic retinopathy. J Diabetes Res. 2014;2014:790902. doi:10.1155/2014/790902
   PubMed Web of Science ®Google Scholar
• Al-Obaide MAI, Singh R, Datta P, et al. Gut microbiota-dependent trimethylamine-N-oxide and serum biomarkers in patients with T2DM and advanced CKD. J Clin Med. 2017;6(9):86. doi:10.3390/jcm6090086
   PubMed Web of Science ®Google Scholar
• Nowiński A, Ufnal M. Trimethylamine N-oxide: a harmful, protective or diagnostic marker in lifestyle diseases? Nutrition (Burbank, Los Angeles County, Calif). 2018;46:7–12. doi:10.1016/j.nut.2017.08.001
   PubMed Web of Science ®Google Scholar
• Chen ML, Zhu XH, Ran L, Lang HD, Yi L, Mi MT. Trimethylamine-N-oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway. J Am Heart Assoc. 2017;6(9). doi:10.1161/jaha.117.006347
   Web of Science ®Google Scholar
• Wang S, Du S, Lv Y, Wang W, Zhang F. Elevated microRNA-20b-3p and reduced thioredoxin-interacting protein ameliorate diabetic retinopathy progression by suppressing the NLRP3 inflammasomes. IUBMB Life. 2020;72:1433–1448. doi:10.1002/iub.2267
   PubMed Web of Science ®Google Scholar
• Wang M, Wang Y, Xie T, et al. Prostaglandin E(2)/EP(2) receptor signalling pathway promotes diabetic retinopathy in a rat model of diabetes. Diabetologia. 2019;62(2):335–348. doi:10.1007/s00125-018-4755-3
   PubMed Web of Science ®Google Scholar
• Wang P, Chen F, Wang W, Zhang XD. Hydrogen sulfide attenuates high glucose-induced human retinal pigment epithelial cell inflammation by inhibiting ROS formation and NLRP3 inflammasome activation. Mediators Inflamm. 2019;2019:8908960. doi:10.1155/2019/8908960
   PubMed Web of Science ®Google Scholar
• Chen H, Zhang X, Liao N, et al. Enhanced expression of NLRP3 inflammasome-related inflammation in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2018;59(2):978–985. doi:10.1167/iovs.17-22816
   PubMed Web of Science ®Google Scholar
• Al-Ofi EA, Anumba DO. Ligands of toll-like receptors 2/4 differentially alter markers of inflammation, adhesion and angiogenesis by monocytes from women with pre-eclampsia in co-culture with endothelial cells. J Reprod Immunol. 2017;121:26–33. doi:10.1016/j.jri.2017.05.002
   PubMed Web of Science ®Google Scholar
• Wu M, Yang S, Wang S, et al. Effect of berberine on atherosclerosis and gut microbiota modulation and their correlation in high-fat diet-fed ApoE-/- mice. Front Pharmacol. 2020;11:223. doi:10.3389/fphar.2020.00223
   PubMed Web of Science ®Google Scholar
• Boini KM, Hussain T, Li PL, Koka S. Trimethylamine-N-oxide instigates NLRP3 inflammasome activation and endothelial dysfunction. Cell Physiol Biochem. 2017;44(1):152–162. doi:10.1159/000484623
   PubMedGoogle Scholar
• Liu Q, Zhang F, Zhang X, et al. Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation. Mol Cell Biochem. 2018;445(1–2):105–115. doi:10.1007/s11010-017-3256-x
   PubMed Web of Science ®Google Scholar
• Loukovaara S, Piippo N, Kinnunen K, Hytti M, Kaarniranta K, Kauppinen A. NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy. Acta Ophthalmol. 2017;95(8):803–808. doi:10.1111/aos.13427
   PubMed Web of Science ®Google Scholar
• Wang Y, Tao J, Yao Y. Prostaglandin E2 activates NLRP3 inflammasome in endothelial cells to promote diabetic retinopathy. Hormone Metabol Res. 2018;50(9):704–710. doi:10.1055/a-0664-0699
   PubMed Web of Science ®Google Scholar
• Chen W, Zhao M, Zhao S, et al. Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline. Inflamm Res. 2017;66(2):157–166. doi:10.1007/s00011-016-1002-6
   PubMed Web of Science ®Google Scholar
• Li Y, Ryu C, Munie M, et al. Association of metformin treatment with reduced severity of diabetic retinopathy in type 2 diabetic patients. J Diabetes Res. 2018;2018:2801450. doi:10.1155/2018/2801450
   PubMed Web of Science ®Google Scholar
• Han J, Li Y, Liu X, et al. Metformin suppresses retinal angiogenesis and inflammation in vitro and in vivo. PLoS One. 2018;13(3):e0193031. doi:10.1371/journal.pone.0193031
   PubMed Web of Science ®Google Scholar
• Wu H, Esteve E, Tremaroli V, et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med. 2017;23(7):850–858. doi:10.1038/nm.4345
   PubMed Web of Science ®Google Scholar
• Herat LY, Ward NC, Magno AL, et al. Sodium glucose co-transporter 2 inhibition reduces succinate levels in diabetic mice. World J Gastroenterol. 2020;26(23):3225–3235. doi:10.3748/wjg.v26.i23.3225
   PubMed Web of Science ®Google Scholar
• Sapieha P, Sirinyan M, Hamel D, et al. The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat Med. 2008;14(10):1067–1076. doi:10.1038/nm.1873
   PubMed Web of Science ®Google Scholar
• Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987;28(10):1221–1227. doi:10.1136/gut.28.10.1221
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhang F, Ding X, et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science. 2018;359(6380):1151–1156. doi:10.1126/science.aao5774
   PubMed Web of Science ®Google Scholar
• Zhao L, Lou H, Peng Y, Chen S, Zhang Y, Li X. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications. Endocrine. 2019;66(3):526–537. doi:10.1007/s12020-019-02103-8
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Adachi K, Sugiyama T, et al. Association of intestinal microbiota with metabolic markers and dietary habits in patients with type 2 diabetes. Digestion. 2016;94(2):66–72. doi:10.1159/000447690
   PubMed Web of Science ®Google Scholar
• Abdel-Latif RG, Heeba GH, Taye A, Khalifa MMA. Lixisenatide, a novel GLP-1 analog, protects against cerebral ischemia/reperfusion injury in diabetic rats. Naunyn Schmiedebergs Arch Pharmacol. 2018;391(7):705–717. doi:10.1007/s00210-018-1497-1
   PubMed Web of Science ®Google Scholar
• Shang J, Liu F, Zhang B, et al. Liraglutide-induced structural modulation of the gut microbiota in patients with type 2 diabetes mellitus. PeerJ. 2021;9:e11128. doi:10.7717/peerj.11128
   PubMed Web of Science ®Google Scholar
• Gonçalves A, Lin CM, Muthusamy A, et al. Protective effect of a GLP-1 analog on ischemia-reperfusion induced blood-retinal barrier breakdown and inflammation. Invest Ophthalmol Vis Sci. 2016;57(6):2584–2592. doi:10.1167/iovs.15-19006
   PubMed Web of Science ®Google Scholar
• Cai X, Li J, Wang M, et al. GLP-1 treatment improves diabetic retinopathy by alleviating autophagy through GLP-1R-ERK1/2-HDAC6 signaling pathway. Int J Med Sci. 2017;14(12):1203–1212. doi:10.7150/ijms.20962
   PubMed Web of Science ®Google Scholar
• Munipally PK, Agraharm SG, Valavala VK, Gundae S, Turlapati NR. Evaluation of indoleamine 2,3-dioxygenase expression and kynurenine pathway metabolites levels in serum samples of diabetic retinopathy patients. Arch Physiol Biochem. 2011;117(5):254–258. doi:10.3109/13813455.2011.623705
   PubMed Web of Science ®Google Scholar
• Rinninella E, Mele MC, Merendino N, et al. The role of diet, micronutrients and the gut microbiota in age-related macular degeneration: new perspectives from the gut-retina axis. Nutrients. 2018;10(11):1677. doi:10.3390/nu10111677
   PubMed Web of Science ®Google Scholar
• Chaiwiang N, Poyomtip T. Microbial dysbiosis and microbiota-gut-retina axis: the lesson from brain neurodegenerative diseases to primary open-angle glaucoma pathogenesis of autoimmunity. Acta Microbiol Immunol Hung. 2019;66(4):541–558. doi:10.1556/030.66.2019.038
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457(7228):480–484. doi:10.1038/nature07540
   PubMed Web of Science ®Google Scholar
• Zinkernagel MS, Zysset-Burri DC, Keller I, et al. Association of the intestinal microbiome with the development of neovascular age-related macular degeneration. Sci Rep. 2017;7:40826. doi:10.1038/srep40826
   PubMed Web of Science ®Google Scholar
• Andriessen EM, Wilson AM, Mawambo G, et al. Gut microbiota influences pathological angiogenesis in obesity-driven choroidal neovascularization. EMBO Mol Med. 2016;8(12):1366–1379. doi:10.15252/emmm.201606531
   PubMed Web of Science ®Google Scholar
• Rowan S, Jiang S, Korem T, et al. Involvement of a gut-retina axis in protection against dietary glycemia-induced age-related macular degeneration. Proc Natl Acad Sci U S A. 2017;114(22):E4472–e4481. doi:10.1073/pnas.1702302114
   PubMed Web of Science ®Google Scholar
• Hammond BR, Fletcher LM, Roos F, Wittwer J, Schalch W. A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast. Invest Ophthalmol Vis Sci. 2014;55(12):8583–8589. doi:10.1167/iovs.14-15573
   PubMed Web of Science ®Google Scholar
• Braakhuis A, Raman R, Vaghefi E. The association between dietary intake of antioxidants and ocular disease. Diseases (Basel, Switzerland). 2017;5(1). doi:10.3390/diseases5010003
   PubMedGoogle Scholar
• Souied EH, Delcourt C, Querques G, et al. Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the nutritional AMD treatment 2 study. Ophthalmology. 2013;120(8):1619–1631. doi:10.1016/j.ophtha.2013.01.005
   PubMed Web of Science ®Google Scholar
• Aoki A, Inoue M, Nguyen E, et al. Dietary n-3 fatty acid, α-tocopherol, zinc, vitamin D, vitamin C, and β-carotene are associated with age-related macular degeneration in Japan. Sci Rep. 2016;6:20723. doi:10.1038/srep20723
   PubMed Web of Science ®Google Scholar
• Zhang QY, Tie LJ, Wu SS, et al. Overweight, obesity, and risk of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2016;57(3):1276–1283. doi:10.1167/iovs.15-18637
   PubMed Web of Science ®Google Scholar